Showing results (61-70 of 172) with videos related to

Sort By:
Pageof 18
Blood|July 17, 2004
Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518Jennifer J Clark, Jan Cools, David P Curley, et al.
Blood|March 24, 2005
Constitutively activated FGFR3 mutants signal through PLCgamma-dependent and -independent pathways for hematopoietic transformationJing Chen, Ifor R Williams, Benjamin H Lee, et al.
Blood|April 1, 2004
Positive and negative regulatory roles of the WW-like domain in TEL-PDGFbetaR transformationJing Chen, Ifor R Williams, Jeffery L Kutok, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2007
Ott1(Rbm15) has pleiotropic roles in hematopoietic developmentGlen D Raffel, Thomas Mercher, Hirokazu Shigematsu, et al.
Blood|April 5, 2003
Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsivenessAmy D Klion, Pierre Noel, Cem Akin, et al.
Molecular and Cellular Biology|November 5, 2008
Ott1 (Rbm15) is essential for placental vascular branching morphogenesis and embryonic development of the heart and spleenGlen D Raffel, Gerald C Chu, Jonathan L Jesneck, et al.
The Journal of Clinical Investigation|June 17, 2004
Stable expression of small interfering RNA sensitizes TEL-PDGFbetaR to inhibition with imatinib or rapamycinJing Chen, Nathan R Wall, Kerry Kocher, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 2006
Activation of FIP1L1-PDGFRalpha requires disruption of the juxtamembrane domain of PDGFRalpha and is FIP1L1-independentElizabeth H Stover, Jing Chen, Cedric Folens, et al.
Cell Stem Cell|November 3, 2010
mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletionJae Y Lee, Daisuke Nakada, Omer H Yilmaz, et al.
Cell|February 27, 2007
The retinoblastoma binding protein RBP2 is an H3K4 demethylaseRobert J Klose, Qin Yan, Zuzana Tothova, et al.
Pageof 18